immunogenicity assessment

bellasmithPublished: November 27, 2017
Published: November 27, 2017

SIAT® in silico immunogenicity assessment is able to analyze and predict the potential immunogenicity of biotherapeutic drug candidates. The protein sequences are analyzed by modern bioinformatics combined with experimental human HLA binding data to estimate the binding affinity of the peptide to HLA, which can predict the potential of the peptide for T cell activation. Our SIAT® in silico immunogenicity assessment service is best fit for early discovery and exploring stage.

Recommend tags
  • immunogenicity assessment+1

immunogenicity assessment